Thijs O. Munnink
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ibrutinib tablet splitting as a practical strategy for dose reduction in the management of drug-drug interactions.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 20, 2026
Target Attainment and Clinical and Biochemical Parameters Associated with the Pharmacokinetics of 12 Tyrosine Kinase Inhibitors.
Journal: Clinical pharmacokinetics
Published: February 03, 2026
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.
Journal: Clinical pharmacokinetics
Published: July 14, 2025
Low-cost generation of clinical-grade, layperson-friendly pharmacogenetic passports using oligonucleotide arrays.
Journal: American journal of human genetics
Published: November 19, 2024
Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma.
Journal: Clinical pharmacokinetics
Published: October 28, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.
Journal: Targeted oncology
Published: May 20, 2024
Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: June 19, 2023
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review.
Journal: Clinical pharmacokinetics
Published: February 12, 2023
Successful treatment of hairy cell leukemia variant with obinutuzumab.
Journal: Annals of hematology
Published: April 08, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026